Literature DB >> 28496854

Sleep Disordered Breathing and the Pathogenesis of Atrial Fibrillation.

Thomas Bitter1, Dieter Horstkotte1, Olaf Oldenburg1.   

Abstract

This review illustrates the importance of sleep disordered breathing in evolution and progression of atrial fibrillation. While in early years associations were mainly attributed to the impact of hypoxemia and hypertension, nowadays multiple, additional pathways have been investigated or are currently under investigation. Sleep disordered breathing has been shown to have a direct impact on mechanical and electrical remodeling. In addition hypercapnia and negative intrathoracic pressure seem to alter atrial electrophysiology. Finally, impacts on inflammation and metabolic dysregulation display the complex interplay between breathing disorders and evolution and progression of atrial fibrillation.

Entities:  

Year:  2013        PMID: 28496854      PMCID: PMC5153063          DOI: 10.4022/jafib.818

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  75 in total

1.  Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients.

Authors:  Maria Matiello; Mercé Nadal; David Tamborero; Antonio Berruezo; Josep Montserrat; Cristina Embid; Jose Rios; Julián Villacastín; Josep Brugada; Lluís Mont
Journal:  Europace       Date:  2010-05-20       Impact factor: 5.214

2.  Sleep-disordered breathing in patients with atrial fibrillation and normal systolic left ventricular function.

Authors:  Thomas Bitter; Christoph Langer; Jürgen Vogt; Mathias Lange; Dieter Horstkotte; Olaf Oldenburg
Journal:  Dtsch Arztebl Int       Date:  2009-03-06       Impact factor: 5.594

3.  Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.

Authors:  P A Wolf; T R Dawber; H E Thomas; W B Kannel
Journal:  Neurology       Date:  1978-10       Impact factor: 9.910

4.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

5.  Obstructive sleep apnea and the recurrence of atrial fibrillation.

Authors:  Ravi Kanagala; Narayana S Murali; Paul A Friedman; Naser M Ammash; Bernard J Gersh; Karla V Ballman; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

6.  Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Susan M Harding
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

Review 7.  Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link.

Authors:  L Lavie; P Lavie
Journal:  Eur Respir J       Date:  2009-06       Impact factor: 16.671

8.  The effect of sleep apnea on plasma and urinary catecholamines.

Authors:  J E Dimsdale; T Coy; M G Ziegler; S Ancoli-Israel; J Clausen
Journal:  Sleep       Date:  1995-06       Impact factor: 5.849

9.  Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea.

Authors:  Nabil Al Lawati; Alan Mulgrew; Rupi Cheema; Stephan vanEeden; Arsalan Butt; John Fleetham; Frank Ryan; Najib Ayas
Journal:  Sleep Breath       Date:  2009-05-05       Impact factor: 2.816

10.  Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation.

Authors:  Ri-Bo Tang; Jian-Zeng Dong; Xing-Peng Liu; Jun-Ping Kang; Shao-Fang Ding; Li Wang; De-Yong Long; Rong-Hui Yu; Xiao-Hui Liu; Shuang Liu; Chang-Sheng Ma
Journal:  Europace       Date:  2008-11-12       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.